Sydney Soirée — CLINUVEL’s Phase III vitiligo program 2023 Announcements . Corporate . News 10.11.2023
CLINUVEL delivering on a long-term strategy with increase in annual revenues, profit 2023 Announcements . Corporate . Financial 29.08.2023
Afamelanotide Significantly Reduces DNA Damage in a Healthy Population 2023 Announcements . Corporate 15.08.2023
SCENESSE® applied under five-year Veterans Affairs contract 2023 Announcements . Corporate 26.07.2023